Phase II Study of S-1 Plus LV (1 Week on and 1 Week Off) as First-line Treatment for Patients With Metastatic Colorectal Cancer
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Overall Response Rate (ORR)
During chemotherapy
No
Hideo Baba, M.D.
Principal Investigator
Graduate School of Medical Sciences Kumamoto University
Japan: Ministry of Health, Labor and Welfare
Taiho10020400
NCT00891332
October 2008
November 2011
Name | Location |
---|